Trajectories of fertility intentions among women living with HIV in South Africa

References

• Bekker, L., Black, V., Myer, L., Rees, H., Cooper, D., Mall, S., … Gilbert, L. (2011). Guideline on safer conception in fertile HIV-infected individuals and couples: Guideline. Southern African Journal of HIV Medicine, 12(2), 31–44. doi: 10.4102/sajhivmed.v12i2.196
   Google Scholar
• Black, V., & Schwartz, S. R. (2018). Issues about periconception use of dolutegravir are reminiscent of early concerns about efavirenz. The Lancet HIV, 5(12), e732–e736. doi: 10.1016/S2352-3018(18)30249-2
   PubMed Web of Science ®Google Scholar
• Bray, B. C., Lanza, S. T., & Tan, X. (2015). Eliminating bias in classify-analyze approaches for latent class analysis. Structural Equation Modeling: A Multidisciplinary Journal, 22(1), 1–11. doi: 10.1080/10705511.2014.935265
   PubMed Web of Science ®Google Scholar
• Calvert, C., & Ronsmans, C. (2013). HIV and the risk of direct obstetric complications: A systematic review and meta-analysis. PLoS One, 8(10), e74848. doi: 10.1371/journal.pone.0074848
   PubMed Web of Science ®Google Scholar
• Clogg, C. C. (1995). Latent class models: Recent developments and prospects for the future. In G. Arminger, C. C. Clogg, & M. E. Sobel (Eds.), Handbook of statistical modeling for the social and behavioral sciences (pp. 311–359). New York, NY: Plenum Press.
   Google Scholar
• European Medicines Agency. (2018). New study suggests risk of birth defects in babies born to women on HIV medicine dolutegravir [press release]. Retrieved from https://www.ema.europa.eu/en/news/new-study-suggests-risk-birth-defects-babies-born-women-hiv-medicine-dolutegravir
   Google Scholar
• Goodman, L. A. (2007). On the assignment of individuals to latent classes. Sociological Methodology, 37, 1–22. doi: 10.1111/j.1467-9531.2007.00184.x
   Web of Science ®Google Scholar
• Hoffman, I. F., Martinson, F. E., Powers, K. A., Chilongozi, D. A., Msiska, E. D., Kachipapa, E. I., … Tsui, A. O. (2008). The year-long effect of HIV-positive test results on pregnancy intentions, contraceptive use, and pregnancy incidence among Malawian women. JAIDS Journal of Acquired Immune Deficiency Syndromes, 47(4), 477–483. doi: 10.1097/QAI.0b013e318165dc52
   PubMed Web of Science ®Google Scholar
• Joint United Nations Programme on HIV/AIDS (UNAIDS). (2015). Progress Report on the Global Plan towards the elimination of new HIV infections among children and keeping their mothers alive. Geneva, Switzerland: 2015. Retrieved from http://www.unaids.org/sites/default/files/media_asset/JC2774_2015ProgressReport_GlobalPlan_en.pdf
   Google Scholar
• Kodzi, I. A., Casterline, J. B., & Aglobitse, P. (2010). The time dynamics of individual fertility preferences among rural Ghanaian women. Studies in Family Planning, 41(1), 45–54. doi: 10.1111/j.1728-4465.2010.00223.x
   PubMed Web of Science ®Google Scholar
• Matthews, L. T., Beyeza-Kashesya, J., Cooke, I., Davies, N., Heffron, R., Kaida, A., … Weber, S. (2018). Consensus statement: Supporting safer conception and pregnancy for men and women living with and affected by HIV. AIDS and Behavior, 22(6), 1713–1724. doi: 10.1007/s10461-017-1777-7
   PubMed Web of Science ®Google Scholar
• Nagin, D. (2005). In: Ebrary academic complete (online collection). Group-based modeling of development [electronic resource] Cambridge, MA: Harvard University Press.
   Google Scholar
• Nagin, D. S., & Odgers, C. L. (2010). Group-based trajectory modeling in clinical research. Annual Review of Clinical Psychology, 6, 109–138. doi: 10.1146/annurev.clinpsy.121208.131413
   PubMed Web of Science ®Google Scholar
• Newell, M. L., Coovadia, H., Cortina-Borja, M., Rollins, N., Gaillard, P., Dabis, F., … Ghent International AIDS Society (IAS) Working Group on HIV Infection in Women and Children. (2004). Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: A pooled analysis. The Lancet, 364(9441), 1236–1243. doi: 10.1016/S0140-6736(04)17140-7
   PubMed Web of Science ®Google Scholar
• Republic of South Africa Department of Health. (2012). South African national contraception and fertility planning policy and service delivery guidelines: A companion to the national contraception clinical guidelines. Pretoria, South Africa. December 2012. Retrieved from http://www.partners-popdev.org/wp-content/uploads/2015/08/National-contraception-family-planning-policy.pdf
   Google Scholar
• Reynolds, H. W., Janowitz, B., Homan, R., & Johnson, L. (2006). The value of contraception to prevent perinatal HIV transmission. Sexually Transmitted Diseases, 33(6), 350–356. doi: 10.1097/01.olq.0000194602.01058.e1
   PubMed Web of Science ®Google Scholar
• Reynolds, H. W., Janowitz, B., Wilcher, R., & Cates, W. (2008). Contraception to prevent HIV-positive births: Current contribution and potential cost savings in PEPFAR countries. Sexually Transmitted Infections, 84(Suppl 2), ii49–ii53. doi:10.1136/sti.2008.030049.
   PubMed Web of Science ®Google Scholar
• Rucinski, K. B., Powers, K. A., Schwartz, S. R., Pence, B. W., Chi, B. H., Black, V., … Pettifor, A. E. (2018). Longitudinal patterns of unmet need for contraception among women living with HIV on antiretroviral therapy in South Africa. PLoS One, 13(12), e0209114. doi: 10.1371/journal.pone.0209114
   PubMed Web of Science ®Google Scholar
• Rucinski, K. B., Schwartz, S. R., Powers, K. A., Pence, B. W., Chi, B. H., Black, V., … Pettifor, A. E. (2019). Fertility intentions and clinical care attendance among women living with HIV in South Africa. AIDS and Behavior. doi: 10.1007/s10461-019-02564-y. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Schwartz, S. R., Bassett, J., Holmes, C. B., Yende, N., Phofa, R., Sanne, I., & Van Rie, A. (2017). Client uptake of safer conception strategies: Implementation outcomes from the Sakh'umndeni safer conception clinic in South Africa. Journal of the International AIDS Society, 20(Suppl 1), 21291.
   PubMed Web of Science ®Google Scholar
• Schwartz, S. R., Bassett, J., Sanne, I., Phofa, R., Yende, N., & Van Rie, A. (2014). Implementation of a safer conception service for HIV-affected couples in South Africa. Aids (london, England), 28(Suppl 3), S277–S285. doi: 10.1097/QAD.0000000000000330
   PubMed Web of Science ®Google Scholar
• Schwartz, S. R., Mehta, S. H., Taha, T. E., Rees, H. V., Venter, F., & Black, V. (2012). High pregnancy intentions and missed opportunities for patient-provider communication about fertility in a South African cohort of HIV-positive women on antiretroviral therapy. AIDS and Behavior, 16(1), 69–78. doi: 10.1007/s10461-011-9981-3
   PubMed Web of Science ®Google Scholar
• Schwartz, S. R., Rees, H., Mehta, S., Venter, W. D., Taha, T. E., & Black, V. (2012). High incidence of unplanned pregnancy after antiretroviral therapy initiation: Findings from a prospective cohort study in South Africa. PLoS One, 7(4), e36039. doi: 10.1371/journal.pone.0036039
   PubMed Web of Science ®Google Scholar
• Schwartz, S., Taha, T. E., Venter, W. D., Mehta, S., Rees, H., & Black, V. (2012). Efavirenz conceptions and regimen management in a prospective cohort of women on antiretroviral therapy. Infectious Diseases in Obstetrics and Gynecology, 2012, 723096. doi: 10.1155/2012/723096
   PubMedGoogle Scholar
• Sennott, C., & Yeatman, S. (2013). Stability and change in fertility preferences among young women in Malawi. International Perspectives on Sexual and Reproductive Health, 38(1), 34–42. doi: 10.1363/3803412
   Web of Science ®Google Scholar
• Steiner, R. J., Black, V., Rees, H., & Schwartz, S. R. (2016). Low receipt and uptake of safer conception messages in routine HIV care: Findings from a prospective cohort of women living with HIV in South Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes. doi: 10.1097/QAI.0000000000000945
   PubMed Web of Science ®Google Scholar
• Taulo, F., Berry, M., Tsui, A., Makanani, B., Kafulafula, G., Li, Q., … Taha, T. E. (2009). Fertility intentions of HIV-1 infected and uninfected women in Malawi: A longitudinal study. AIDS and Behavior, 13(Suppl 1), 20–27. doi: 10.1007/s10461-009-9547-9
   PubMed Web of Science ®Google Scholar
• United States Food and Drug Administration. (2018). Drug safety communication: FDA to evaluate potential risk of neural tube birth defects with HIV medicine dolutegravir (Juluca, Tivicay, Triumeq). Retrieved from https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-evaluate-potential-risk-neural-tube-birth-defects-hiv-medicine
   Google Scholar
• WHO. (2018). Statement on DTG. Retrieved from http://www.who.int/medicines/publications/drugalerts/Statement_on_DTG_18May_2018final.pdf
   Google Scholar
• WHO. (2019). WHO recommends dolutegravir as preferred HIV treatment option in all populations. Retrieved from https://www.who.int/news-room/detail/22-07-2019-who-recommends-dolutegravir-as-preferred-hiv-treatment-option-in-all-populations
   Google Scholar
• Wilcher, R., Petruney, T., Reynolds, H. W., & Cates, W. (2008). From effectiveness to impact: Contraception as an HIV prevention intervention. Sexually Transmitted Infections, 84(Suppl 2), ii54–ii60. doi:10.1136/sti.2008.030098.
   PubMed Web of Science ®Google Scholar
• Yeatman, S., Sennott, C., & Culpepper, S. (2013). Young women's dynamic family size preferences in the context of transitioning fertility. Demography, 50(5), 1715–1737. doi: 10.1007/s13524-013-0214-4
   PubMed Web of Science ®Google Scholar
• Zash, R., Holmes, L., Diseko, M., Jacobson, D. L., Brummel, S., Mayondi, G., … Gaolathe, T. (2019). Neural-tube defects and antiretroviral treatment regimens in Botswana. New England Journal of Medicine, 381(9), 827–840. doi: 10.1056/NEJMoa1905230
   PubMed Web of Science ®Google Scholar
• Zash, R., Makhema, J., & Shapiro, R. L. (2018). Neural-tube defects with dolutegravir treatment from the time of conception. New England Journal of Medicine, 379(10), 979–981. doi: 10.1056/NEJMc1807653
   PubMed Web of Science ®Google Scholar